SCHEMBL931503

SCHEMBL931503

N=C(c1ccc(F)cc1)c1cccc(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.53
CTSL P07711 4/20 0.49
HSD11B1 P28845 1/20 0.46
PARP1 P09874 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.42
MAOB P27338 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
CXCR2 P25025 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15372989 0.78 C1S (0.47) C1SCTSLPARP1MEN1KMT2A
SCHEMBL932511 0.78 C1S (0.53) C1SCTSLPARP1MEN1KMT2A
SCHEMBL9125529 0.78 CES2 (0.59) C1SCTSLHSD11B1PARP1MEN1
SCHEMBL2282074 0.78 CTSL (0.49) C1SCTSLHSD11B1PARP1MEN1
SCHEMBL1635669 0.78 PARP1 (0.53) CTSLHSD11B1PARP1MEN1KMT2A
SCHEMBL931923 0.77 C1S (0.49) C1SPARP1MEN1KMT2AALDH1A1
SCHEMBL8277840 0.77 C1S (0.45) C1SPARP1MEN1KMT2ACYP1A2
SCHEMBL932545 0.77 C1S (0.45) C1SPARP1MEN1KMT2AATM
SCHEMBL18540697 0.77 C1S (0.57) C1SCTSLPARP1MEN1KMT2A
SCHEMBL4476448 0.77 CES2 (0.52) MAOBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed